Dubai Creek Harbor to hand over first homes in Q1 2019

Creek Island Dubai is a one-of-a-kind waterfront destination that will bring lavish island living to over 33,500 residents.
Updated 27 August 2018

Dubai Creek Harbor to hand over first homes in Q1 2019

Dubai Creek Harbor, the 6-square-kilometer mega-development nearly twice the size of Downtown Dubai, will welcome its first residents early next year. A vibrant new community will take shape in a Riviera-style neighborhood as the first residences in Creek Island Dubai, the premier district in Dubai Creek Harbor, are being readied for hand-over. 

Creek Island Dubai is a one-of-a-kind waterfront destination that will bring lavish island living to over 33,500 residents. Set against the backdrop of Dubai’s skyline and the natural beauty of the historic creek, Creek Island Dubai is only 10 minutes from the Dubai International Airport and the Burj Khalifa, as well as overlooking the Ras Al-Khor Wildlife Sanctuary, home to rich mangroves and migratory birds including the pink flamingos. 

The Creek Marina will be home to diverse retail, dining and leisure venues. In addition to yachting facilities, complete with a modern yacht club, three hotels, a promenade, landscaped pedestrian walkways, and art installations will greet residents and visitors. It will be home to many of the city’s parks, gourmet restaurants, cafés and entertainment venues.

The first homes to be delivered in Creek Island Dubai are in Dubai Creek Residences, a six-tower residential development with 872 homes. 

All six towers feature panoramas over Dubai Creek Harbor and Downtown Dubai on the opposite side of the Dubai Creek. Nearly 90 percent of the construction has been completed for hand-over in the first quarter of 2019.

More than 4,000 residents will be the first ones to move in to their new address. Work on all supporting infrastructure is progressing as per schedule with easy access from the Ras Al-Khor thoroughfare already in place. 

Creek Island Dubai will also be connected to the mainland by three bridges. Creek Marina will also be home to the Vida Harbor Point, a 286-room upscale lifestyle hotel similar to harbor hotels in cities such as Singapore and Shanghai, which will also open in 2019.

Meanwhile, work on the other residential developments launched in Creek Island Dubai is progressing as per schedule. These include Creekside 18, with 500 apartments, scheduled for completion in the first half of 2020, with over 40 percent of the construction completed. 

Harbor Views with 762 apartments, also to be handed over in the first half of 2020, is over 36 percent completed, while nearly 20 percent construction has been completed on Creek Horizon, featuring 556 apartments due for handover in mid-2020, and The Cove, a low-rise waterfront sanctuary, with 276 apartments, will be delivered in the first half of 2020. 


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.